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Stroke is one of the leading causes of death and 
disability worldwide. Clinical and preclinical ex-
perimental studies highlight the importance of 
inflammation in both acute and delayed neuro-
nal tissue damage after ischemic stroke; however, 
the mechanisms and cells involved in this neuro-
inflammation are not fully understood. There is 
currently no available treatment targeting the 
acute immune response that develops in the 
brain after transient focal ischemia. Therefore, 
we sought to identify novel T cell–derived cyto-
kines that contribute to acute cerebral reperfu-
sion using the mouse model of transient middle 
cerebral artery occlusion (tMCAO).
During the reperfusion of infarcted brain tis-
sue, leukocytes accumulate in the injured brain 
where, in addition to clearing cell debris, they 
promote secondary tissue injury (Yilmaz and 
Granger, 2010). Within the acute phase of isch-
emic reperfusion (I/R) injury there are multiple 
waves of cell infiltration of macrophages, neutro-
phils, and lymphocytes (Gelderblom et al., 2009). 
Brain-infiltrating T cells have also been widely 
reported in stroke and animal models of stroke 
and are thought to have acute detrimental and 
delayed protective effects (Magnus et al., 2012). 
Conventionally, the protective role of T cells has 
been attributed to the accumulation of regula-
tory T cells within the CNS in later stages of re-
perfusion injury. These T cells produce a variety 
of cytokines including TGF and IL-10, which 
are both antiinflammatory and neuroprotective. 
(Liesz et al., 2009; Stubbe et al., 2013). In addi-
tion to having an established role in delayed   
neuroprotection, Kleinschnitz et al. (2013) have 
recently shown that CD4+ CD25+ regulatory   
T cells also promote acute ischemic injury through 
interaction with the cerebral vasculature. The 
acute detrimental effects can be further divided 
into early (24 h) and late (72 h) phases, with 
IL-17 production by nonconventional  T cells 
(less common T cell subset associated with mu-
cosal tissues) possibly accounting for the latter by 
promoting neutrophil accumulation (Gelderblom 
et al., 2012).
The mechanisms of the early detrimental ef-
fects of T cells after cerebral ischemia are least 
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T lymphocytes are key contributors to the acute phase of cerebral ischemia reperfusion 
injury, but the relevant T cell–derived mediators of tissue injury remain unknown. Using a 
mouse model of transient focal brain ischemia, we report that IL-21 is highly up-regulated 
in the injured mouse brain after cerebral ischemia. IL-21–deficient mice have smaller 
infarcts, improved neurological function, and reduced lymphocyte accumulation in the 
brain within 24 h of reperfusion. Intracellular cytokine staining and adoptive transfer 
experiments revealed that brain-infiltrating CD4+ T cells are the predominant IL-21 source. 
Mice treated with decoy IL-21 receptor Fc fusion protein are protected from reperfusion 
injury. In postmortem human brain tissue, IL-21 localized to perivascular CD4+ T cells in the 
area surrounding acute stroke lesions, suggesting that IL-21–mediated brain injury may be 
relevant to human stroke.
© 2014 Clarkson et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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of several previously reported inflammatory genes, we found 
that IL-21 was one of the most highly expressed inflammatory 
genes among those measured (Fig. 1 a). Gene expression levels 
from arrays were normalized to interquartile spot intensity. 
Arrays did not differ systemically in gene expression levels be-
fore or after normalization (not depicted). This increase in IL-21 
gene expression was confirmed by real-time (RT) PCR analy-
sis, which detected a >24-fold relative increase in IL-21 gene 
expression in the ipsilateral ischemic brain tissues compared 
with the contralateral hemisphere at 24 h reperfusion (Fig. 1 b). 
IL-21 was not detectable by this method in healthy brain tis-
sue (Fig. 1 b).
IL-21–deficient mice are protected from acute  
neuronal injury after cerebral I/R injury
Whether IL-21 contributes to ischemic tissue injury had not 
been directly studied. However, in the last few years it has be-
come evident that IL-21 expression is associated with acute 
rejection in mice after kidney, heart, or liver allograft (Baan et al., 
2007; Hecker et al., 2009; Xie et al., 2010). Because these 
models also involve reperfusion of ischemic tissues, these find-
ings support the potential role of IL-21 in I/R injury.
We evaluated the levels of cerebral I/R injury in IL-21–
deficient (IL-21 KO) mice. Infarct volumes in IL-21 KO mice 
were reduced to 35% of the infarct volumes observed in con-
genic C57BL6/J WT mice as early as 24 h after tMCAO, as 
measured by triphenyltetrazolium chloride (TTC; Fig. 1 c). 
Similar effects were also seen at 4 d (not depicted) and 7 d after 
tMCAO (Fig. 1 d), indicating that IL-21 contributes to both 
immediate and delayed brain injury and suggesting that in the 
absence of IL-21 tissue repair can occur. Analysis of intracra-
nial vascular anatomy revealed no differences between WT and   
IL-21 KO mice in the patency of the posterior communicating 
artery that would account for the observed differences in tissue 
injury (Fig. 1 g). Nor did we observe differences between WT 
and IL-21 KO mice in heart rate, or blood pressure before or 
after tMCAO (Fig. 1 h). WT and IL-21 KO CD4+ T cells, 
CD8+ T cells, and CD11b+ myeloid cells showed no difference 
in IL-2, IL-17A, IFN-, or TNF production when stimulated 
in vitro (Fig. 2, g–l). The reduction in infarct volumes corre-
sponded with less weight loss (unpublished data), less spleen   
atrophy (Fig. 2 c), and improved neurological functioning in 
IL-21 KO mice compared with WT mice as assessed by both 
grip strength (Fig. 1 e) and Bederson (Fig. 1 f) scoring 1, 4, and 
7 d after tMCAO.
We measured accumulation of monocytes and lympho-
cytes in the brain after tMCAO in IL-21 KO and WT animals 
(gating strategy in Fig. 2 a). We did not observe significant dif-
ferences in the rate of accumulation of monocytes (CD45high
CD11b+Ly6chigh), microglia (CD45intCD11b+), B cells (B220+), 
 T cells (TCR+), NK, or NKT cells (NK1.1+) in the 
ischemic brain of WT and IL-21 KO mice after 1, 4, and 7 d 
of reperfusion (unpublished data). In contrast, as early as 1 d 
after tMCAO, IL-21 KO mice showed significantly dimin-
ished cerebral accumulation of CD4+ T cells and CD8+ T cells 
understood. Several laboratories have reported reduced neuro-
logical deficit and infarct volumes at 24–48 h reperfusion in   
T cell–deficient mice after tMCAO (Yilmaz and Granger, 2010). 
After tMCAO, recombination activating gene 1–deficient 
(RAG1 KO) mice, which lack T and B lymphocytes, have sig-
nificantly smaller brain injury compared with controls; whereas, 
adoptive transfer of WT CD4+ helper T cells or CD8+ cyto-
toxic T cells increases stroke infarct volumes within 24 h after 
ischemia in these mice (Kleinschnitz et al., 2010). Additionally, 
TCR-transgenic mice and mice lacking co-stimulatory TCR 
signaling molecules were fully susceptible to acute I/R injury, 
indicating that T cell involvement at early time points is anti-
gen-independent (Kleinschnitz et al., 2010). These data dem-
onstrate that conventional CD4+ or CD8+   T cells exacerbate 
acute injury after cerebral ischemia independently of TCR li-
gation, and this effect seems to be concomitant with an early 
increase in T cell infiltration into the postischemic brain, which 
many have reported to be between 3 and 48 h (Yilmaz et al., 
2006; Gelderblom et al., 2009).
Recent findings suggest that, in the postischemic brain, 
within hours of reperfusion T cells accumulate in postcapillary 
segments of periinfarct inflamed cerebral microvasculature 
characterized by high endothelial expression of chemokines 
and adhesion molecules. These postcapillary venules have been 
postulated to allow accumulating immune cells to activate each 
other and promote platelet adhesion in a process termed 
thrombo-inflammation (Nieswandt et al., 2011). Much research 
has been devoted to identifying T cell factors that promote 
thrombo-inflammation (Barone et al., 1997; Hedtjärn et al., 
2002; Yilmaz et al., 2006; Shichita et al., 2009; Gelderblom et al., 
2012); however, to our knowledge no study has yet identified 
the T cell–derived factors responsible for the early increase in 
infarct volumes at 24 h reperfusion. Here, we present data that 
identify IL-21 as a key CD4+ T cell–derived inflammatory fac-
tor that contributes to increased early ischemic tissue injury.
RESULTS AND DISCUSSION
Robust up-regulation of IL-21 during cerebral I/R injury
IL-21 is closely related to IL-2 and IL-15 and signals through 
the IL-21 receptor, which is comprised of an IL-21–specific   
 subunit and a common  subunit shared with IL-2, IL-7, IL-9, 
and IL-15. IL-21 is known to regulate immune responses by 
promoting antibody production, T cell–mediated immunity, 
and NK cell and CD8+ T cell cytotoxicity. Recently, others 
have shown that stress signals from necrotic tissue can induce 
rapid IL-21 production from naive T cells (Holm et al., 2009), 
and co-stimulation with TLR3 ligands during polyclonal T cell 
activation significantly increases IL-21 secretion that contributes 
to small intestine localized pediatric celiac disease (van Leeuwen 
et al., 2013). To test whether IL-21 is up-regulated in brain after 
ischemic necrosis induced by MCAO and to better understand 
the cytokines involved in T cell–mediated cerebral I/R injury, 
we measured changes in inflammatory gene expression in the 
brain within 24 h after tMCAO in mice using PCR-based 
gene array analysis. In addition to verifying the up-regulation JEM Vol. 211, No. 4  597
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in either tissue compared with WT experimental animals. Nor 
did we observe a difference between WT and IL-21 KO mice 
in the frequency of lymphocytes producing the antiinflam-
matory cytokine IL-10 among B cells (B220+), CD8+ T cells, 
or CD4+ T cells (unpublished data). These data demonstrate 
that IL-21 deficiency is protective at acute time points after 
tMCAO and IL-21 levels in the CNS correlate with early in-
filtration of T cells without affecting regulatory T or B cell 
accumulation or IL-10 cytokine production during the acute 
period (day 1–4).
after tMCAO compared with WT mice (Fig. 2 e) and these 
differences persisted at day 7 (Fig. 2 f ). These differences were 
not reflected in the spleen before or after tMCAO (Fig. 2 b). 
IL-21 has also been shown to be produced by and modulate 
the function of regulatory T cells (Peluso et al., 2007; Battaglia 
et al., 2013), which begin to accumulate in the brain after 
tMCAO. Thus, we compared the frequency of regulatory 
CD4 T cells expressing the marker Foxp3 in the brain and 
spleen 24 h after tMCAO in WT and IL-21 KO mice. IL-21 
KO mice exhibited no difference in regulatory T cell abundance 
Figure 1.  IL-21 is up-regulated early in 
mouse brain, and IL-21–deficient mice are 
protected after tMCAO. GeArray S Series 
Mouse Autoimmune and Inflammatory Re-
sponse gene array of transcripts expressed in 
pooled brain tissues 24 h after tMCAO or 
sham procedure (n = 3–6 mice per group). 
(a) Bar graphs show PCR array spot intensity 
of genes with a greater than sixfold difference 
in gene expression in tMCAO compared with 
sham, normalized to the interquartile mean 
spot intensity. (b) IL-21 mRNA expression 
level in ipsilateral hemisphere relative to con-
tralateral hemisphere 24 h after tMCAO (n = 3 
per group). Mann-Whitney rank sum test  
*, P < 0.05. Plots show median, lower, and upper 
quartile (box) and range (error bars). Infarct 
volumes of WT and IL-21 KO mice 24 h after 
tMCAO (c) and 7 d after tMCAO (d). Represen-
tative images of TTC-stained 2-mm brain 
slices shown below (n = 5–7 mice per group). 
WT and IL-21 KO mice grip strength (e) and 
Bederson score (f) at 1, 4, and 7 d after 1 h 
tMCAO (n = 7–8 for each group). (g) Brain 
vasculature of C57BL/6 and IL-21KO mice 
perfused transcardially with carbon lampblack 
(C198-500; Thermo Fisher Scientific) in 20% 
gelatin ddH2O. Arrows indicate anterior cere-
bral (ACA), MCA, posterior cerebral (PCA), 
basilar (BA), and vertebral arteries (VA), show-
ing point of occlusion (white circle). High 
magnification images demonstrate no differ-
ence in patency of the posterior communicat-
ing artery (PComA, arrows). (h) Heart rate and 
blood pressure of WT and IL-21 KO mice be-
fore and after tMCAO (n = 3–4 mice per 
group). Data are representative of 2–3 inde-
pendent experiments. **, P < 0.01; ***, P < 
0.001; ****, P < 0.0001 by Student’s t test 
(single comparison) or one-way ANOVA (mul-
tiple comparisons). Error bars indicate SD.598 IL-21 promotes brain injury after stroke | Clarkson et al.
Figure 2.  Lymphocyte recruitment to brain is diminished in IL-21 deficient mice. (a) Gating strategy for leukocytes isolated from brain after 
MCAO. (b) WT and IL-21 KO spleen cells 24 h after tMCAO or sham procedure (n = 3 mice per group). (c) Relative change in spleen weight of WT and IL-21 
KO mice after tMCAO (n = 3–7 mice per group). (d) Percentage of blood and spleen CD4+ T cells expressing IL-21 after 5-h ex vivo stimulation with PMA 
(10 ng/ml) and Ionomycin (1 µg/ml) 4 d after MCAO or control treatment. (e and f) Leukocyte accumulation in the brain of WT mice compared with IL-21 
KO mice 1, 4, and 7 d after tMCAO (n = 3–6 mice per group). (g–k) In vitro cytokine expression by WT and IL-21 KO CD4+ and CD8+ T cells after 5-h 
stimulation under indicated conditions with or without recombinant mouse IL-21 (100 ng/ml). (l) TNF production by CD11b+ myeloid cells stimulated with 
LPS (500 ng/ml) for 5 h with or without recombinant mouse IL-21 (100 ng/ml). Cells isolated from n = 3 mice per group. Data are representative of two to 
four independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Student’s t test (single comparison) or one-way ANOVA (multiple 
comparisons). Error bars indicate SD (b–d and g–l) and SEM (e, f).JEM Vol. 211, No. 4  599
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IL-21 blockade is protective in tMCAO
We treated WT mice with IL-21 receptor Fc protein (IL-21R.
Fc) using a previously described protocol (Jang et al., 2009; 
McGuire et al., 2011; Spolski et al., 2012). We administered 
500 µg of IL-21R.Fc i.p. 1 h before tMCAO. As measured by 
TTC staining, treated mice showed significantly reduced in-
farct volumes compared with control-treated mice 24 h after 
tMCAO (Fig. 4 a). We found a similarly protective effect in 
mice treated with IL-21R.Fc protein (500 µg i.p.) 2 h after ini-
tiation of reperfusion (Fig. 4 a). These differences were associ-
ated with decreased locomotor function (decreased resistance 
to  lateral  push  and  increased  circling  behavior)  in  control-
treated  mice  compared  with  those  treated  with  IL-21R.Fc 
(Fig. 4 b and Video 1). Although we cannot exclude the pos-
sibility that IL-21R.Fc exhibits its blocking effect in periph-
eral immune compartments, using ELISA for human IgG4 we 
were able to observe that—upon i.p. injection—soluble IL-21R.
Fc accumulates in the CNS of mice after tMCAO (Fig. 4 c).
IL-21 presence localizes with CD4 staining  
in human stroke tissue
IL-21+ cells were recently detected in human brain tissue 
during different neuroinflammatory conditions (Tzartos et al., 
2011). Thus, we stained groups of postmortem brain tissue from 
IL-21 is primarily produced  
by brain-infiltrating CD4+ T cells
We measured intracellular IL-21 production by various cell 
populations. IL-21–producing cells were not detected by flow 
cytometry among cells isolated from healthy brain, but could 
be detected among mononuclear cells isolated from isch-
emic brain 24 h after tMCAO. Gating on IL-21+ cells revealed 
that the majority of these cells were CD4+ T cells (Fig. 3 a). 
IL-21–producing CD4+ T cells were also detected at low lev-
els among cells isolated from blood, but not spleen, of healthy 
WT mice, and these levels were unaffected after transient ce-
rebral ischemia (Fig. 2 d), indicating that the increase in IL-21 
production was limited to CD4+ T cells recovered from the 
postischemic brain. Next, we adoptively transferred WT or 
IL-21 KO CD4+ T cells into lymphocyte-deficient RAG2 
KO mice. Purity of transferred CD4+ T cells was confirmed 
by flow cytometry to be 95% (Fig. 3 b). As shown previ-
ously (Kleinschnitz et al., 2010), we observed markedly re-
duced infarcts in RAG KO mice compared with WT mice, 
and infarct volumes could be restored to WT levels in RAG2 
KO by adoptively transferring WT CD4+ T cells. Most im-
portantly, RAG2 KO mice that received WT CD4+ T cells 
had significantly larger infarcts than those receiving IL-21 
KO CD4+ T cells (Fig. 3 c).
Figure 3.  IL-21 is primarily produced by brain-infiltrating CD4+ T cells. (a) Intracellular cytokine staining of lymphocytes isolated from n = 5 
pooled healthy WT, ischemic IL-21/, or ischemic WT mouse brains 24 h after tMCAO or sham procedure showing IL-21 versus CD8 expression. Histo-
grams show CD4, NK1.1, and TCR expression on IL-21+ cells from ischemic WT brain. (b) CD45, CD4, and LFA-1 expression by negative fractions purified 
from WT and IL-21/ lymph node cells by CD4+ negative selection using magnetic cell separation before transfer into RAG2/ recipients. (c) Infarct 
volume in WT mice (n = 4), RAG2/ mice (n = 4), RAG2/ mice + WT CD4 T cells (n = 10), and RAG2/ mice + IL-21/ CD4 T cells (n = 10) 24 h  
after tMCAO. Representative TTC-stained 2-mm mouse brain slices shown on top. Data are representative of two independent experiments. **, P < 0.01;  
***, P < 0.001; ****, P < 0.0001 one-way ANOVA. Error bars indicate SD.600 IL-21 promotes brain injury after stroke | Clarkson et al.
Figure 4.  Blockade of IL-21 signaling before or after tMCAO reduces infarct size in WT mice. (a) Infarct volumes 24 h after tMCAO in WT mice 
treated with 500 µg recombinant mIL-21R.Fc or PBS 1 h before (pretreatment) or 2 h after (posttreatment) surgery. Representative TTC-stained brain 
slices shown on left (n = 3–4 mice per group). (b) Still image from Video 1 depicting behavioral differences between WT mice posttreated with IL-21R.Fc 
or PBS. (c) IL-21R.Fc protein levels in the indicated organs 20–24 h after tMCAO in WT mice injected with 500 µg IL-21R.Fc 2 h after start of reperfusion 
(n = 2–4 mice per group). N.D., not detected. Data are representative of two independent experiments. **, P < 0.01; ***, P < 0.001, by Student’s t test. Error 
bars indicate SEM. Representative images of postmortem paraffin-embedded human acute stroke lesions stained with control sera (d), or primary anti-
bodies against CD4 (e and g [ii-iii]), IL-21 (f and g [iii]), or eosin (g [i]) visualized with Fast Red (d, e, and g) and/or DAB (d, f, and g [iii]) and counterstained 
with hematoxylin. High magnification images are shown on right. Arrows indicate positive staining. Bars, 50 µm.JEM Vol. 211, No. 4  601
Brief Definitive Report
T  cells  that  can  secrete  IL-21  were  detected  within  the 
CSF-filled subarachnoid and perivascular spaces during cere-
bral infarction in humans.
Neuronal cells express IL-21 receptor and up-regulate 
autophagy genes in response to IL-21
RT-PCR analysis of primary mouse neurons and murine neu-
ronal cell lines (Neuro2A) indicated that IL-21R expression 
was higher on neuronal cells than on other brain cells, includ-
ing astrocytes and endothelial cells (Fig. 5, a and c). This is con-
sistent with another report where in situ hybridization detected 
neuron-restricted IL-21R expression in inflamed human brain 
tissue (Tzartos et al., 2011). Moreover, treating Neuro2a cells 
with IL-21 after in vitro oxygen glucose deprivation (OGD) 
significantly increased cell death as measured by XTT cell 
patients with acute and chronic stroke lesions. In acute infarcts, 
rare CD4+ T cells were found in the necrotic brain parenchyma 
(Fig. 4 g, ii, arrows), which was predominantly infiltrated by 
foamy macrophages (Fig. 4 g, i). In contrast, CD4+ T cells were 
consistently found within the Virchow Robins space of vessels 
bordering acute infarcts (not depicted) and in the subarachnoid 
space adjacent to meningeal vessels (arrows, Fig. 4 e, i). IL-21 
staining was limited almost exclusively to these perivascular 
spaces. Compared with control stained tissue (Fig. 4 d, i), anti–
IL-21 staining labeled cells extensively in the subarachnoid 
space of deep sulci penetrating the infarcted tissue—showing   
a similar distribution to CD4+ cells in serial sections (arrows, 
Fig. 4 f). Additionally, double staining with antibodies for 
CD4 and IL-21 revealed the presence of CD4+ IL-21+ cells 
in this perivascular niche (arrow, Fig. 4 g, iii). In summary, CD4+  
Figure 5.  IL-21 promotes autophagy expres-
sion in neuronal cells after hypoxia/ischemia. 
(a) Il21r mRNA expression relative to GAPDH 
expression levels is shown in normoxic and hy-
poxic primary mouse neurons after OGD or con-
trol treatment. (b) Viability of Neuro2A cells 
treated with the indicated doses of IL-21 after 
OGD. (c) Il21r mRNA expression relative to 
GAPDH in neuronal (Neura2A), astrocytic, and 
endothelial cell lines (MB114) expressed relative 
to BMDC expression. (d) ATG6 expression in pri-
mary neurons treated with PBS, etoposide, or  
32–256 ng/ml rIL-21 for 4 h after 1–2 h oxygen 
glucose deprivation as measured by RT-PCR. Cells 
treated in triplicate. (e) Number of ATG6+ cells per 
field in the same regions of WT and IL-21 KO 
mouse brains after tMCAO as assessed by im-
mune staining (n = 3 mice per group). Arrows 
indicate ATG-6+ cells in periinfarcted brain tissue 
of WT and IL-21 KO mice. Bars, 100 µm. Data  
are representative of two independent experi-
ments. *, P < 0.05; **, P < 0.01; ***, P < 0.001;  
****, P < 0.0001 by Student’s t test (single com-
parison) or one-way ANOVA (multiple compari-
sons). Error bars indicate SEM.602 IL-21 promotes brain injury after stroke | Clarkson et al.
of the superior thyroid artery, the ECA was dissected distally and coagulated 
along with the terminal lingual and maxillary artery branches. The internal ca-
rotid artery (ICA) was isolated, and the extracranial branch of the ICA was then 
dissected and ligated. A standardized polyamide resin glue-coated 6.0 nylon 
monofilament (3021910; Doccol Corp) was introduced into the ECA lumen, 
and then advanced 9–9.5 mm in the ICA lumen to block MCA blood flow. 
During the entire procedure, mouse body temperature was kept between 37 
and 38°C with a heating pad. The suture was withdrawn 60 min after occlu-
sion. The incision was closed, and the mice underwent recovery.
Infarction size measurement. After 24 h reperfusion, mice were sacrificed 
and brains were removed and frozen at 80°C for 5 min. 2-mm coronal 
slices were made with a rodent brain matrix (Ted Pella, Inc.). The sections 
were stained for 20 min at 37°C with 2% TTC (Sigma-Aldrich). Infarction 
volume was calculated with the method reported by Swanson et al. (1990) to 
compensate for brain swelling in the ischemic hemisphere. In brief, the sec-
tions were scanned, and the infarction area in each section was calculated by 
subtracting the noninfarct area of the ipsilateral side from the area of the 
contralateral side with National Institutes of Health image analysis software, 
ImageJ. Infarction areas on each section were summed and multiplied by sec-
tion thickness to give the total infarction volume.
Gene array and RT-PCR. Ipsilateral brain hemispheres were dissected and 
stored in RNAlater (QIAGEN) at 4°C until further use. Total RNA was ex-
tracted and purified with RNeasy Protect Mini kit (QIAGEN) according to 
the manufacturer’s instructions. Purified RNA samples were analyzed by   
GeArray S Serious Mouse Autoimmune and Inflammatory Gene array   
(SuperArray; Bioscience Corporation). Results from GeArray were filtered 
for genes with spot intensities higher than the mean local background of the 
bottom 75% of nonbleeding spots. For RT-PCR, 1 µg total RNA from each 
sample was reverse transcribed using SuperScript II first strand cDNA syn-
thesis kit (Invitrogen). RT-PCR was performed on a Smart Cycler (Model SC 
100–1; Cepheid) using IL-21 TaqMan gene expression assay (Mm00517640_m1; 
Applied  Biosystems),  RT2  qPCR  Primer  assay  for  mouse  Becn1 
(PPM32434A; SABiosciences), or RT2 qPCR Primer Assay for Mouse IL21r 
(PPM03762A; SABiosciences). The data were normalized to an internal ref-
erence gene, GAPDH.
Mononuclear cell isolation and flow cytometry. Brains were removed 
from perfused animals, weighed, minced, transferred to Medicon inserts, and 
ground in a MediMachine (BD) for 20–30 s. The cell suspension was washed 
with HBSS, and cells were resuspended in 70% Percoll (Pharmacia) and over-
laid with 30% Percoll. The gradient was centrifuged at 2,250 g for 30 min at 
4°C without brake. The interface was removed and washed once for further 
analysis. CD11b-positive and -negative fractions were isolated using Imag 
anti-CD11b magnetic particles (BD), following the manufacturer’s protocol. 
A total of 106 cells were incubated for 30 min on ice with saturating concen-
trations of labeled antibodies with 40 µg/ml unlabeled 2.4G2 mAb to block 
binding to Fc receptors, and then washed 3 times with 1% BSA in PBS.
Single-cell suspensions from various tissues were cultured at 37°C in 
10% FBS in RPMI 1640 media supplemented with GolgiStop (BD) in the pres-
ence of either phorbol myristate acetate (50 ng/ml) and ionomycin (1 µg/ml) 
for 5 h. After surface staining with antibodies against CD4, NK1.1, and 
TCR, cell suspensions were fixed and permeabilized by Cytofix/Cy-
toperm solution (BD), followed by staining with anti–IL-21 antibodies.   
Fluorochrome-labeled antibodies against CD45, CD11b, Ly6c, B220, CD4, 
CD8a, NK1.1, IFN-, and appropriate isotype controls were purchased from 
BD. Fluorochrome-labeled antibody against IL-21 and TCR was pur-
chased from eBioscience. Cell staining was acquired on a FACSCalibur or 
LSRII (BD) and analyzed with FlowJo (Tree Star) software version 5.4.5.
Neurofunctional assessment. Neuromuscular coordination was assessed by 
grip strength test, as previously described (Kleinschnitz et al., 2010). For this 
test, mice were placed on a horizontal string midway between two supports. 
Mice were scored from 0 to 5 as follows: 0, falls off within 2 s; 1, hangs on with 
viability assay (Fig. 5 b). In subsequent studies we found that 
treatment of primary neurons with IL-21 up-regulated mRNA 
levels of the autophagy associated gene ATG6 (Fig. 5 d). These 
data suggest that IL-21 could directly affect neuronal autoph-
agy during ischemic injury, which has been implicated in neu-
ronal death in infarcted and periinfarcted brain tissue. Thus, we 
stained WT and IL-21 KO postischemic brain tissues for ATG6. 
We observed significantly fewer ATG6+ cells in infarcted brain 
tissue of IL-21 KO mice compared with WT, suggesting that 
IL-21 may contribute to increased cerebral autophagy after 
stroke (Fig. 5 e).
In conclusion, we implicate IL-21 as a lymphocyte-derived 
factor with a pronounced effect on brain injury after focal isch-
emia in mice. We also present data demonstrating that IL-21–
producing CD4+ T cells are present in the brain of patients 
with acute stroke. These data warrant investigation of the thera-
peutic potential of IL-21–modifying treatments in isolation 
and combination with current anti-thrombotic treatments for 
ischemic stroke.
MATERIALS AND METHODS
Ethics statement. C57BL/6 WT mice were obtained from The Jackson 
Laboratory. IL-21–deficient mice (IL-21tm1Lex) were purchased from the Mu-
tant Mouse Regional Resources Center. All mice underwent 1 h tMCAO 
and 24 h reperfusion. All animal procedures used in this study were con-
ducted in strict compliance with the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals and approved by the University of 
Wisconsin Center for Health Sciences Research Animal Care Committee. 
All mice (25 g) were anesthetized with 5% halothane for induction and 
1.0% halothane for maintenance vaporized in N2O and O2 (3:2), and all ef-
forts were made to minimize suffering.
Regional cerebral blood flow (rCBF) measurement. Changes in rCBF 
at the surface of the left cortex were recorded using a blood perfusion monitor 
(Laserflo BPM2; Vasamedics) with a fiber optic probe (0.7 mm diam). The tip 
of the probe was fixed with glue on the skull over the core area supplied by the 
MCA (2 mm posterior and 6 mm lateral from bregma). Changes in rCBF after 
MCAO were recorded as a percentage of the baseline value. Mice included in 
these investigations had >80% relative decrease in rCBF during MCAO.
Investigation of intracranial vasculature. WT and IL-21 KO mice were 
anesthetized with ketamine (100 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.). 
After thoracotomy was performed, a cannula was introduced into the ascend-
ing aorta through the left ventricle. Transcardial perfusion fixation was per-
formed with 2 ml saline and 2 ml of 3.7% formaldehyde. Carbon lampblack 
(C198-500; Thermo Fisher Scientific) in an equal volume of 20% gelatin in 
ddH2O (1 ml) was injected through the cannula. The brains were removed 
and fixed in 4% PFA overnight at 4°C. Posterior communicating arteries 
(PComA) connect vertebrobasilar arterial system to the Circle of Willis and 
internal carotid arteries, and its development affects brain sensitivity to isch-
emia among different mouse strains (Barone et al., 1993). Development of 
PComA in both hemispheres was examined and graded on a scale of 0–3, as 
reported previously (Majid et al., 2000). 0, no connection between anterior 
and posterior circulation; 1, anastomosis in capillary phase (present but poorly 
developed); 2, small truncal PComA; 3, truncal PComA.
Focal ischemia model. Focal cerebral ischemia in mice was induced by oc-
clusion of the left MCA, as described previously (Longa et al., 1989). Operators 
performing surgeries were masked to experimental groups. In brief, the left 
common carotid artery was exposed, and the occipital artery branches of the 
external carotid artery (ECA) were isolated and coagulated. After coagulation JEM Vol. 211, No. 4  603
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Statistical analyses and quality standards. All surgeries were performed 
in a blinded manner by a third party and measurements masked where possi-
ble. Infarct volume measurements from TTC stained sections were averaged 
from two to three independent blinded observers. Based on power calcula-
tions, n = 3–10 sex- and age-matched mice were used for each experiment 
and group assignment was randomized. Among animals receiving MCAO 
procedure, 86.5% of WT mice, 93.5% of IL-21KO mice, and 100% of 
RAG2KO mice were included in analysis. Mice were excluded due to prema-
ture death (13.5% of WT mice, 3.2% of IL-21 KO mice) or vessel variation 
(3.2% of IL-21KO mice). Results are given as means ±1 SD. Multiple com-
parisons were made using one-way ANOVA. Where appropriate, two-tailed 
Student’s t test analysis was used for comparing measures made between two 
groups. For comparison of RT-PCR data, nonparametric Mann-Whitney 
rank sum analysis was used. P-values <0.05 were considered significant.
Online supplemental material. Video 1 shows groups of WT C57BL6 
mice treated with 500 µg IL-21R.Fc or PBS control via i.p. injection. On-
line supplemental material is available at http://www.jem.org/cgi/content/ 
full/jem.20131377/DC1.
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